Resilience turns to Harvard for biologics manufacturing tech, inks 5-year R&D pact
Biomanufacturing technologies company Resilience is partnering with Harvard in a deal that could see innovations from the university’s labs commercialized under new businesses. Resilience has committed $30 million in funding to support Harvard biomanufacturing research.
Source: medcitynews.com